Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
Type:
Grant
Filed:
November 23, 2011
Date of Patent:
December 22, 2020
Assignee:
CHEMI NUTRA
Inventors:
Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jager
Abstract: Phosphatidic acid, lyso-phosphatidic acid, and/or phospholipase D can be administered to exercising mammals to increase muscle mass and strength. These actives can be administered orally to aging, bedridden or cachectic patients, as well as resistance training individuals, to improve nitrogen balance. The oral administration of phosphatidic acid as well as other actives described herein was found to increase muscle hypertrophy, strength, and lean body mass, and to decrease body fat in subjects, for example, when combined with resistance training.
Type:
Application
Filed:
May 23, 2013
Publication date:
December 19, 2013
Applicant:
Chemi Nutra
Inventors:
Lorenzo DE FERRA, Marvin A. HEUER, Scott L. HAGERMAN, Martin PURPURA, Ralf JAEGER
Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
Type:
Grant
Filed:
November 30, 2008
Date of Patent:
February 28, 2012
Assignee:
Chemi Nutra, LLC
Inventors:
Martin Purpura, Ralf Jäger, Scott L. Hagerman